CD47 and neoplasm: Indeed, SIINFEKL+ CD8+ T cells were significantly enhanced by CD47 × PD‐L1 BisAb treatment in the tumor compared to controls (Figure 1g) but were numerically unchanged in the spleen and MFP (Figure 1f and Supplementary figure 3c).